Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
Clinical trial NCT04667793 · UNKNOWN
Trial details
- NCT number
- NCT04667793
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-31
- Primary completion
- 2023-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.